The role of biomarker services in drug discovery and development is increasing incessantly in several therapeutic areas such as oncology, cardiology, immunology, metabolic and neuroscience.
Recommended Buyer's Guides
The identification of biomarkers associated with a patient’s responsiveness to investigational drugs can help in achieving significant efficacy with minimum adverse events in clinical trials on the targeted patient population.
Biomarker identification and adoption are especially valuable in rare diseases and precision medicine development, which requires a wide array of services throughout the entire process of clinical research such as DNA sequencing, gene expression profiling, large molecule bioanalysis, cell separation technology and more. It also requires innovative technologies and state-of-the-art platforms to support both pre-clinical and clinical biomarker studies.
Finding the top biomarker analysis in clinical trials companies in clinical research
Clinical Trials Arena has listed some of the leading biomarker services companies in clinical research based on its intel, insights, and decades-long experience in the sector. The list includes companies that provide various products and services, including:
- Biomarker detection and biomarker R&D services for membrane proteins and antibodies
- Discovery, assay development and testing of biomarkers
- Clinical biomarker services, and clinical kitting services
- Biomarker plan and biomarker validation services
- Screening biomarkers, biomarker testing, and custom assay development
- Biomarker analysis services
- Biomarker platform technologies such as immune monitoring, flow cytometry, bioanalytical testing, immunophenotyping, and cytokine analysis
- Assessments of nucleic acid therapeutics
- Formulation and product chemistry
- Anatomic pathology
- In-vitro drug development, histoculture drug response assays, methylation studies, and high throughput data analysis
- Genomic and tissue biomarker services, and cell services, and
- Transfer of proprietary assays
The information contained within the download document is intended for clinical research coordinators, research associates, clinical biomarker specialists, clinical scientists, clinical science directors, clinical biomarker development scientists, clinical trial associates, project specialists, data analysts, biostatisticians, clinical data associates, product managers, and any other individual involved in biomarker services in clinical research.
The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision.
Importance of biomarker services for pharma
The successful identification of a suitable biomarker is an important factor for drug development. It helps pharmaceutical companies in the detection and classification of pathological processes and monitoring the course of therapy.
The biomarker-driven approach for patient selection strategies and the development of precision medicines has the potential to increase the success rate of the drug development process, reduce expenses, and ultimately improve patient health outcomes.
For full details (including contact details) on the leading companies within this space, download the free Buyer’s Guide below:
Frequently asked questions
-
What role do biomarkers play in clinical trials?
Biomarkers are crucial in clinical trials as they help determine a patient’s response to investigational drugs, improving drug efficacy and minimising side effects. Biomarkers guide patient selection, monitor treatment effectiveness, and support the development of precision medicine by identifying biological indicators linked to disease progression.
-
How are biomarkers identified in clinical trials?
Biomarkers are identified through various techniques like DNA sequencing, gene expression profiling, and bioanalytical testing. These methods help detect specific biological signals that relate to drug response, safety, or disease status.
-
What are the benefits of using biomarkers in drug development?
The use of biomarkers accelerates drug development by enabling personalised treatment plans and improving trial success rates. They help in identifying suitable patient populations, reducing trial costs, and increasing the likelihood of regulatory approval by demonstrating clear efficacy and safety profiles.
-
What services do biomarker companies provide?
Biomarker companies offer services such as biomarker discovery, validation, and clinical assay development. These include technologies like immune monitoring, flow cytometry, and genomics to support clinical trial data analysis and ensure precise results.
-
How do biomarkers support precision medicine?
Biomarkers allow for the development of precision medicine by identifying individual patient differences in disease mechanisms and drug response. This enables the creation of targeted therapies tailored to specific biological profiles, improving treatment outcomes and reducing adverse effects.